Table 4

OARSI responder criteria

Number (%) of Responders

0.03 mg

(N = 7)

0.1 mg

(N = 6)

0.3 mg

(N = 6)

1 mg

(N = 6)

All

(N = 25)

Placebo

(N = 8)


Week 4

3 (42.9%)

4 (66.7%)

1 (16.7%)

2 (33.3%)

10 (40%)

1 (12.5%)

Week 8

3 (42.9%)

4 (66.7%)

2 (33.3%)

2 (33.3%)

11 (44%)

0 (0%)

Week 12

1 (14.3%)

4 (66.7%)

2 (33.3%)

1 (16.7%)

8 (32%)

1 (12.5%)

Week 24

1 (14.3%)

5 (83.3%)

2 (33.3%)

1 (20%)

9 (37.5%)

1 (12.5%)


Hunter et al. BMC Musculoskeletal Disorders 2010 11:232   doi:10.1186/1471-2474-11-232

Open Data